A company hopes to pioneer a non-invasive continuous glucose monitor for wearable devices
As OEMs continue to pack more features into smartwatches, a company claims to have developed a way to measure glucose levels that does away with invasive methods. Founded in 2018, Movano has now received US$27 million in funding to realise the project.
According to the company, its solution uses Radio Frequencies (RF) to calculate glucose levels and could be embedded in wearable devices. These measurements can apparently be delivered in real-time without the need to resort to invasive methods of measure glucose levels. If the technology bears fruit, then it may be possible to measure glucose levels by making contact with just someone's skin.
Movano hopes that its solution can be used as a "valuable preventative care tool" to reduce the frequency of doctor and hospital visits. The company hopes to use its latest round of funding to finalise prototypes and aid it in preparing for initial user trials. Movano plans to have a working prototype by the end of 2021.
It is unclear whether the company plans to sell a dedicated smartwatch or licence its technology to OEMs. However, since a working prototype will not be ready until nearly 2022 at the earliest, do not expect any smartwatches with continuous glucose monitors (CGM) for a while yet.